| # | Title | Journal | Year | Citations |
|---|
| 1 | PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer | Breast Care | 2016 | 20,872 |
| 2 | Trastuzumab-Induced Hepatotoxicity: A Case Report | Breast Care | 2013 | 2,975 |
| 3 | A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition | Breast Care | 2013 | 280 |
| 4 | Comparison of Ductoscopy, Galactography, and Imaging Modalities for the Evaluation of Intraductal Lesions: A Critical Review | Breast Care | 2013 | 274 |
| 5 | Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients | Breast Care | 2016 | 248 |
| 6 | St. Gallen 2011: Summary of the Consensus Discussion | Breast Care | 2011 | 194 |
| 7 | Breast Cancer Care in India: The Current Scenario and the Challenges for the Future | Breast Care | 2008 | 191 |
| 8 | The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer | Breast Care | 2018 | 135 |
| 9 | St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment | Breast Care | 2019 | 131 |
| 10 | Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries | Breast Care | 2019 | 125 |
| 11 | St. Gallen 2013: Brief Preliminary Summary of the Consensus Discussion | Breast Care | 2013 | 123 |
| 12 | Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications | Breast Care | 2013 | 117 |
| 13 | St. Gallen/Vienna 2017: A Brief Summary of the Consensus Discussion about Escalation and De-Escalation of Primary Breast Cancer Treatment | Breast Care | 2017 | 109 |
| 14 | Advantages and Disadvantages of Mammography Screening | Breast Care | 2011 | 108 |
| 15 | 13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013) | Breast Care | 2013 | 98 |
| 16 | Granulomatous Mastitis: A Therapeutic and Diagnostic Challenge | Breast Care | 2018 | 97 |
| 17 | Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer | Breast Care | 2016 | 92 |
| 18 | St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer | Breast Care | 2021 | 90 |
| 19 | AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2016 | Breast Care | 2016 | 88 |
| 20 | HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer | Breast Care | 2013 | 85 |
| 21 | Biological Subtypes of Triple-Negative Breast Cancer | Breast Care | 2017 | 85 |
| 22 | St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion | Breast Care | 2015 | 82 |
| 23 | Current Status and Future Projections of Breast Cancer in Asia | Breast Care | 2015 | 77 |
| 24 | AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019 | Breast Care | 2019 | 72 |
| 25 | AGO Recommendations for Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2013 | Breast Care | 2013 | 68 |
| 26 | Online Survey of Patients with Breast Cancer on Complementary and Alternative Medicine | Breast Care | 2014 | 68 |
| 27 | Local Treatment of the Axilla in Early Breast Cancer: Concepts from the National Surgical Adjuvant Breast and Bowel Project B-04 to the Planned Intergroup Sentinel Mamma Trial | Breast Care | 2014 | 68 |
| 28 | Differentiation between Phyllodes Tumors and Fibroadenomas Based on Mammographic Sonographic and MRI Features | Breast Care | 2016 | 68 |
| 29 | The German SUCCESS C Study – The First European Lifestyle Study on Breast Cancer | Breast Care | 2010 | 65 |
| 30 | Oligometastatic Breast Cancer: A Shift from Palliative to Potentially Curative Treatment? | Breast Care | 2014 | 65 |
| 31 | Male Breast Cancer | Breast Care | 2008 | 61 |
| 32 | Targeted Therapies in Triple-Negative Breast Cancer | Breast Care | 2015 | 60 |
| 33 | Germline Mutations in Triple-Negative Breast Cancer | Breast Care | 2017 | 59 |
| 34 | Metabolic Syndrome and Breast Cancer: Is There a Link? | Breast Care | 2014 | 57 |
| 35 | Tumor-Associated Antigens in Breast Cancer | Breast Care | 2012 | 56 |
| 36 | Polycyclic Aromatic Hydrocarbons and Breast Cancer: A Review of the Literature | Breast Care | 2015 | 55 |
| 37 | The Course of Anxiety and Depression in Patients with Breast Cancer and Gynaecological Cancer | Breast Care | 2008 | 54 |
| 38 | Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response | Breast Care | 2017 | 53 |
| 39 | Evaluation of Social Support, Quality of Life, and Body Image in Women with Breast Cancer | Breast Care | 2016 | 52 |
| 40 | Physical Activity, Exercise and Breast Cancer - What Is the Evidence for Rehabilitation, Aftercare, and Survival A Review | Breast Care | 2018 | 52 |
| 41 | Influence of Lifestyle Factors on Breast Cancer Risk | Breast Care | 2014 | 51 |
| 42 | AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021 | Breast Care | 2021 | 51 |
| 43 | Radionuclide Therapy of Bone Metastases | Breast Care | 2012 | 50 |
| 44 | Role of Breast Ultrasound for the Detection and Differentiation of Breast Lesions | Breast Care | 2010 | 49 |
| 45 | Mammography Screening: Evidence, History and Current Practice in Germany and Other European Countries | Breast Care | 2011 | 49 |
| 46 | Subclinical Breast Cancer: Minimally Invasive Approaches. Our Experience with Percutaneous Radiofrequency Ablation vs. Cryotherapy | Breast Care | 2013 | 48 |
| 47 | Management of Breast Cancer Patients with Chemotherapy-Induced Neutropenia or Febrile Neutropenia | Breast Care | 2014 | 48 |
| 48 | Adaptive Coping and Spirituality as a Resource in Cancer Patients | Breast Care | 2007 | 47 |
| 49 | Fungating Wounds – Multidimensional Challenge in Palliative Care | Breast Care | 2011 | 47 |
| 50 | Breast Cancer Risks and Risk Prediction Models | Breast Care | 2015 | 47 |
